Veronica Alba
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine.
Journal: The Journal of antimicrobial chemotherapy
Published: November 22, 2023
Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation.
Journal: International journal of molecular sciences
Published: June 22, 2022
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy.
Journal: International journal of molecular sciences
Published: January 13, 2022
Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control.
Journal: Frontiers in immunology
Published: November 25, 2021
Differential miRNA plasma profiles associated with the spontaneous loss of HIV-1 control: miR-199a-3p and its potential role as a biomarker for quick screening of elite controllers.
Journal: Clinical and translational medicine
Published: April 26, 2021
High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients.
Journal: EBioMedicine
Published: August 14, 2020
Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection.
Journal: EBioMedicine
Published: February 06, 2019
Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control.
Journal: The Journal of infectious diseases
Published: August 14, 2018
A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients.
Journal: AIDS (London, England)
Published: December 28, 2017
Last Updated: 09/26/2026